Nicole R. Hadas - Net Worth and Insider Trading
Nicole R. Hadas Net Worth
The estimated net worth of Nicole R. Hadas is at least $840,103 dollars as of 2024-10-10. Nicole R. Hadas is the SVP, Chief Legal Officer of Akebia Therapeutics Inc and owns about 651,243 shares of Akebia Therapeutics Inc (AKBA) stock worth over $840,103. Details can be seen in Nicole R. Hadas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicole R. Hadas has not made any transactions after 2024-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nicole R. Hadas
Nicole R. Hadas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicole R. Hadas owns 1 companies in total, including Akebia Therapeutics Inc (AKBA) .
Click here to see the complete history of Nicole R. Hadas’s form 4 insider trades.
Insider Ownership Summary of Nicole R. Hadas
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2024-05-13 | SVP & General Counsel & Sec. |
Nicole R. Hadas Latest Holdings Summary
Nicole R. Hadas currently owns a total of 1 stock. Nicole R. Hadas owns 651,243 shares of Akebia Therapeutics Inc (AKBA) as of May 13, 2024, with a value of $840,103.
Latest Holdings of Nicole R. Hadas
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2024-05-13 | 651,243 | 1.29 | 840,103 |
Holding Weightings of Nicole R. Hadas
Nicole R. Hadas Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicole R. Hadas has made a total of 8 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 12,016 shares on May 13, 2024, which brought Nicole R. Hadas around $15,140.
Insider Trading History of Nicole R. Hadas
- 1
Nicole R. Hadas Trading Performance
Nicole R. Hadas Ownership Network
Nicole R. Hadas Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Nicole R. Hadas is the SVP & General Counsel & Sec. of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & Chief Medical Officer Steven Keith Burke , and director & CEO & President John P. Butler .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Nicole R. Hadas made 4 insider transaction in Akebia Therapeutics Inc (AKBA) with a net sale of 88,587. Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 149,723 shares made by Michel Dahan , a net sale of 106,103 shares made by Steven Keith Burke , and a net sale of 84,303 shares made by John P. Butler .
In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 492,283 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,283 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Nicole R. Hadas Mailing Address
Above is the net worth, insider trading, and ownership report for Nicole R. Hadas. You might contact Nicole R. Hadas via mailing address: 20 Pilgram Drive, Winchester Ma 01890.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
